
Cryoport, Inc.
- Jurisdiction
United States - ISIN
US2290503075 (CYRX )- Sectors
Scores
- Fair value (Benjamin Graham formula)
- N/A
- Financial strength (Piotroski F-Value)
-
5
/ 9
- Fundamental strength relative to industry (Mohanram G-Value)
-
2
/ 7
Profile
Cryoport, Inc., a life sciences services company, provides temperature-controlled logistics solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. Read full profile
Fundamentals
- Net revenue
€183.24M - Gross margin
42.9% - EBIT
-€101.56M - EBIT margin
-55.4% - Net income
-€91.98M - Net margin
-50.2%
Statement period: - (published )
Estimates
Fiscal Year | Net revenue | Net income |
---|---|---|
|
| |
|
| |
|
|
Stock price
Dividends
No dividend payouts
Analyst ratings
No analyst ratings available
Insider Transactions
Name | Title | Transaction Date | Shares | Price | Value |
---|---|---|---|---|---|
Hariri Robert J | N/A |
|
|
|
|
STEFANOVICH ROBERT | Chief Financial Officer |
|
|
|
|
Mandalam Ramkumar | N/A |
|
|
|
|
Earnings Calls
Investor transactions
Name | Shares | Value | Last change | Change type |
---|---|---|---|---|
Peter Brown |
|
|
|
Buy |
Earnings Calls
Latest earnings call: May 7, 2024 (Q1 2024)